299908-79-5 Usage
Uses
Used in Pharmaceutical Synthesis:
(4R,5S)-4-cyclohexyl-5-phenyl-butyrolactone is used as an intermediate in the synthesis of pharmaceuticals, leveraging its unique structural properties to contribute to the development of new drugs.
Used in Agrochemical Production:
(4R,5S)-4-cyclohexyl-5-phenyl-butyrolactone is also utilized in the production of agrochemicals, where its specific stereochemistry and functional groups can be advantageous for the creation of effective and targeted products.
Used in Organic Synthesis:
(4R,5S)-4-cyclohexyl-5-phenyl-butyrolactone serves as a building block in organic synthesis, allowing for the construction of more complex molecules with potential applications in various industries.
Used in Medicinal Chemistry:
Due to its structural features, (4R,5S)-4-cyclohexyl-5-phenyl-butyrolactone has potential applications in medicinal chemistry, where it can be used to design and develop novel therapeutic agents.
Used in Drug Development:
Its potential applications extend to drug development, where understanding the compound's properties and interactions can lead to the creation of innovative pharmaceuticals with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 299908-79-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,9,9,0 and 8 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 299908-79:
(8*2)+(7*9)+(6*9)+(5*9)+(4*0)+(3*8)+(2*7)+(1*9)=225
225 % 10 = 5
So 299908-79-5 is a valid CAS Registry Number.
299908-79-5Relevant academic research and scientific papers
Highly enantioselective syntheses of anti homoaldol products by (-)-sparteine-mediated lithiation/transmetalation/substitution of N-Boc allylic amines
Whisler, Marna C.,Vaillancourt, Louis,Beak, Peter
, p. 2655 - 2658 (2007/10/03)
(equation presented) (-)-Sparteine-mediated lithiation/transmetalation/substitution of N-Boc allylic amines provides anfi-configured homoaldol precursors in yields of 38-85% and enantiomeric ratios of 83:17-99:1. Subsequent O-protection and hydrolysis all
